DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Rosenstock J, Mathieu C, Chen H. et al.
Dapagliflozin versus saxagliptin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin.
Arch Endocri and Metabol 2018;
62: 424-430
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.